Purchase Order 75N95023P00351
Award Date 7/3/23
Potential Completion Date 6/4/25
Potential Value $50K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Israel
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Yale University, a private non-profit research institution, on September 20, 2023. The contract, valued at $737,562.00, is for investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV (PLWH). The period of performance is from September 20, 2024 to...
- <p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
- This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Brain Research And Development Services LTD, a foreign-owned for-profit organization that manufactures goods. The contract has a ceiling value of $90,000.00 and a period of performance through May 30, 2017. It does not have a set-aside designation. The contract was awarded on September 24, 2015 and is related to the BRAIN (Brain Research through Advancing Innovative...
- This is a $33,700 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Usona Institute, Inc. The contract has an ultimate completion date of August 31, 2026 and does not utilize a set-aside designation. The contract is for services to be performed in Bethesda, Maryland. Usona Institute, Inc. is a non-profit organization that has been awarded this federal contract but does not appear to have any prior federal prime contract or...
- This federal contract award was granted by the National Institute on Drug Abuse (NIDA), a civilian agency, to Idea Bio-Medical LTD, a for-profit organization, on September 9, 2015. The contract has a firm fixed price of $122,500.00 and a completion date of October 30, 2015. No set-aside designation was used. The contract type is a purchase order and does not appear to be associated with a larger contract vehicle. The provided information does not indicate any major subcontractors or additional...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Children's Research Institute, a non-profit pediatric research organization based in Washington, D.C. The $185,241 contract has an ultimate completion date of September 29, 2027 and was awarded on September 30, 2025. The contract is not set-aside. Children's Research Institute is a highly active recipient of federal...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $250,000.00 firm-fixed-price purchase order to the Baruch S. Blumberg Institute, a non-profit organization and foundation, for a project related to the "NATURAL PRODUCTS EXTRACTS LIBRARY" program. The award did not use a set-aside. The place of performance is Doylestown, Pennsylvania, and the award date was August 14, 2017, with a completion date of September 14, 2017.
- <p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, has awarded a $27,000 firm-fixed-price purchase order contract to the Massachusetts Institute of Technology (MIT) for MWORKS CONSULTING & DEVELOPMENT services. The contract period of performance is from September 20, 2024 to March 19, 2025, with a final completion date of March 19, 2025. This contract does not have a set-aside designation.</p>
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
This is a $49,998.42 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse, a civilian federal agency, to Bar-Haim Yair, a non-profit organization located in Rockville, Maryland. The contract has an ultimate completion date of June 4, 2025 and was awarded on July 3, 2023. The contract does not have a set-aside designation. Based on the agency, this contract is likely related to the National Institute on Drug Abuse's research and programmatic initiatives focused on drug abuse and addiction.
Generated 6/6/25, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Terminate for Convenience | $0 | 6/4/25 | |
| P00001 | Exercise an Option | $25.0k | 6/25/24 | |
| Not listed | Not listed | $25.0k | 6/30/23 |